InnovAge Holding Corp. Stock-Based Compensation
InnovAge Holding Corp. (INNV) reported Stock-Based Compensation of $7.05 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-09-09
- InnovAge Holding Corp. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.73M, a 11.87% increase year-over-year.
- InnovAge Holding Corp. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.79M, a 12.00% decline year-over-year.
- InnovAge Holding Corp. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.22M, a 35.11% decline year-over-year.
- InnovAge Holding Corp. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.31M, a 6.80% increase year-over-year.
- InnovAge Holding Corp. share-based payment arrangement, noncash expense for fiscal 2026 was $7.05M, a 7.49% decline from fiscal 2025.
- InnovAge Holding Corp. share-based payment arrangement, noncash expense for fiscal 2025 was $7.62M, a 11.52% increase from fiscal 2024.
- InnovAge Holding Corp. share-based payment arrangement, noncash expense for fiscal 2024 was $6.83M, a 48.26% increase from fiscal 2023.
- InnovAge Holding Corp. share-based payment arrangement, noncash expense for fiscal 2023 was $4.61M, a 23.24% increase from fiscal 2022.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $3.52M derived: sum of 2 quarters · filed 2026-09-09 | $4.74M derived: sum of 3 quarters · filed 2026-09-09 | $7.05M 10-K · filed 2026-09-09 |
| 2026-03-31 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $3.01M derived: sum of 2 quarters · filed 2026-05-08 | $5.31M 10-Q · filed 2026-05-08 | $6.86M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $3.52M 10-Q · filed 2026-02-03 | $5.07M derived: sum of 3 quarters · filed 2026-09-09 | $7.11M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $2.31M 10-Q · filed 2025-11-04 | $3.86M derived: sum of 2 quarters · filed 2026-09-09 | $5.89M derived: sum of 3 quarters · filed 2026-09-09 | $7.77M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $3.58M derived: sum of 2 quarters · filed 2026-09-09 | $5.46M derived: sum of 3 quarters · filed 2026-09-09 | $7.62M 10-K · filed 2026-09-09 |
| 2025-03-31 | $2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $3.91M derived: sum of 2 quarters · filed 2026-05-08 | $6.07M 10-Q · filed 2026-05-08 | $7.76M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $4.04M 10-Q · filed 2026-02-03 | $5.73M derived: sum of 3 quarters · filed 2026-02-03 | $7.28M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $2.16M 10-Q · filed 2025-11-04 | $3.85M derived: sum of 2 quarters · filed 2025-11-04 | $5.40M derived: sum of 3 quarters · filed 2025-11-04 | $7.17M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $3.24M derived: sum of 2 quarters · filed 2025-09-09 | $5.01M derived: sum of 3 quarters · filed 2025-09-09 | $6.83M 10-K · filed 2025-09-09 |
| 2024-03-31 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | $3.32M derived: sum of 2 quarters · filed 2025-05-06 | $5.14M 10-Q · filed 2025-05-06 | $6.29M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | $3.59M 10-Q · filed 2025-02-04 | $4.74M derived: sum of 3 quarters · filed 2025-02-04 | $5.92M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | $1.82M 10-Q · filed 2024-11-05 | $2.98M derived: sum of 2 quarters · filed 2024-11-05 | $4.15M derived: sum of 3 quarters · filed 2024-11-05 | $5.22M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $2.33M derived: sum of 2 quarters · filed 2024-09-10 | $3.40M derived: sum of 3 quarters · filed 2024-09-10 | $4.61M 10-K · filed 2024-09-10 |
| 2023-03-31 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | $2.25M derived: sum of 2 quarters · filed 2024-05-07 | $3.46M 10-Q · filed 2024-05-07 | $4.61M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | $2.28M 10-Q · filed 2024-02-06 | $3.43M derived: sum of 3 quarters · filed 2024-02-06 | $4.28M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | $1.21M 10-Q · filed 2023-11-07 | $2.36M derived: sum of 2 quarters · filed 2023-11-07 | $3.21M derived: sum of 3 quarters · filed 2023-11-07 | $3.99M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $2.00M derived: sum of 2 quarters · filed 2023-09-12 | $2.78M derived: sum of 3 quarters · filed 2023-09-12 | $3.74M 10-K · filed 2023-09-12 |
| 2022-03-31 | $845.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | $1.63M derived: sum of 2 quarters · filed 2023-05-09 | $2.59M 10-Q · filed 2023-05-09 | $3.15M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $783.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $1.74M 10-Q · filed 2023-02-07 | $2.30M derived: sum of 3 quarters · filed 2023-02-07 | $2.83M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $958.00K 10-Q · filed 2022-11-08 | $1.52M derived: sum of 2 quarters · filed 2022-11-08 | $2.05M derived: sum of 3 quarters · filed 2022-11-08 | $2.58M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $1.09M derived: sum of 2 quarters · filed 2022-09-13 | $1.62M derived: sum of 3 quarters · filed 2022-09-13 | $1.66M 10-K · filed 2022-09-13 |
| 2021-03-31 | $530.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | $1.06M derived: sum of 2 quarters · filed 2022-05-10 | $1.10M 10-Q · filed 2022-05-10 | $1.24M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $526.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | $572.00K 10-Q · filed 2022-02-09 | $708.00K derived: sum of 3 quarters · filed 2022-02-09 | |
| 2020-09-30 | $46.00K 10-Q · filed 2021-11-09 | $182.00K derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $543.00K 10-K · filed 2021-09-23 | ||
| 2020-03-31 | $407.00K 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |